We confirmed that exposure of CD34+/CD38− AML cells to the EZH2 inhibitor EZH2i increased the levels of both PTEN and p16 in parallel with suppression of H3K27me3 (S3 Fig). Here, PTEN is linked to acute myeloid leukemia.